Chlamydia Trachomatis Antikörper (Biotin)

Produktnummer ABIN112697

Der Ziege Polyklonal Anti-Chlamydia Trachomatis Antikörper wurde für WB und EIA validiert. Er ist geeignet, Chlamydia Trachomatis in Proben von Chlamydia trachomatis zu detektieren.

Kurzübersicht für Chlamydia Trachomatis Antikörper (Biotin) (ABIN112697)

Target: Chlamydia Trachomatis

Reaktivität: Chlamydia trachomatis

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser Chlamydia Trachomatis Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Produktdetails anti-Chlamydia Trachomatis Antikörper (Biotin)

Immunogen: Purified MOMP from strain L2

Anwendungsinformationen

Applikationshinweise: Suitable for use with avidin and streptavidin amplification systems for fluorescencemicroscopy.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 4-5 mg/mL (OD280 nm, E0.1% = 1.4)

Buffer: 0.01 M PBS, pH 7.2 containing 0.09 % sodium azide as preservative. Without stabilizer.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu Chlamydia Trachomatis

Target: Chlamydia Trachomatis

Substanzklasse: Bacteria

Hintergrund: Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5 % to 10 %. Chlamydia is one of the leading causes of blindness in underdeveloped countries.